AGER and diabetes mellitus: In diabetes, the chronic activation of RAGE signaling in diabetes disrupts the balance of bone remodeling, by suppressing osteoblast-mediated bone formation and enhancing osteoclast-mediated bone resorption [34]-[39], further compromising bone integrity.